Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;62(6):812-821.
doi: 10.1111/ijd.16555. Epub 2022 Dec 23.

Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines

Affiliations

Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines

Karla I Ligeralde-Bascones et al. Int J Dermatol. 2023 Jun.

Abstract

Background: Basal cell carcinoma (BCC) is the most common cutaneous malignancy. Multiple risk factors are associated in the development of BCC, with ultraviolet light and genetics playing major roles.

Aims: The departments of dermatology, medical oncology, ophthalmology, otorhinolaryngology, head and neck surgery, plastic surgery, and radiation oncology of the Jose R. Reyes Memorial Medical Center, Manila, Philippines, have convened and formulated consensus statements on the diagnosis and management of BCC patients seen in the institution.

Conclusion: The summary of the recommendations is: (1) Surgery is the treatment of choice for BCC. The range of margins (2-4 mm) depends on the type of BCC. (2) Mohs micrographic surgery (MMS) is indicated for high risk BCC. (3) Topical treatment with imiquimod or 5-flourouracil (5-FU) may be used for superficial BCC. (4) Destructive methods (cryotherapy, curettage and electrodessication, photodynamic therapy) may be used for low risk BCC. (5) Medical and/or radiation therapy is advised for cases where surgery is contraindicated or tumor is not amenable to surgery. Metastasis of this malignancy is rare. Follow-up, which may continue up until 2 years, is recommended for high risk BCC.

PubMed Disclaimer

References

    1. Oh C, Jin A, Koh W. Trends of cutaneous basal cell carcinoma, squamous cell carcinoma, and melanoma among the Chinese, Malays, and Indians in Singapore from 1968-2016. JAAD Int. 2021;4:39-45.
    1. Gloster H, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55(5):741-60.
    1. Serquiña BN. Demographic and Clinical Profile of Patients Diagnosed Histopathologically with Basal Cell Carcinoma and Squamous Cell Carcinoma at Jose R. Reyes Memorial Medical Center: A 10-year Cross Sectional Study. Manila, Philippines: Department of Dermatology, Jose R. Reyes Memorial Medical Center; 2021 34 leaves.
    1. Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, et al. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer. 2019;118:10-34.
    1. McDaniel B, Badri T, Steele R. Basal cell carcinoma. StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2021 2022 Jan. PMID: 29494046. https://pubmed.ncbi.nlm.nih.gov/29494046/ [accessed on 10 December 2021]

LinkOut - more resources